Concepedia

Author

Baozhen Ke

The University of Texas MD Anderson Cancer Center

Also Known As

Baozhen Ke

26

Publications

1.8K

Citations

11

H-Index

24

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterChina Medical UniversityThe University of Texas Health Science Center at HoustonBrown FoundationHarbin Medical University
BK

About

Baozhen Ke is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

1.1K

2

Cell Biology

4

4

1.1K

3

Immunology

2

2

989

4

Nephrology

1

1

44

5

Pharmacology

1

1

965

Baozhen Ke

×

11

Publications

1.7K

Citations

10

H-Index

YearCitations

PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis

Junwei Hou, Rongce Zhao, Weiya Xia,

Nature Cell Biology

2020

965

TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Zhou Jiang, Seung-Oe Lim, Meisi Yan,

Journal of Clinical Investigation

2021

300

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

Lei Nie, Yongkun Wei, Fei Zhang,

Nature Communications

2019

96

Renal Expression of the C3a Receptor and Functional Responses of Primary Human Proximal Tubular Epithelial Cells

Michael Braun, Rose Y. Reins, Tong-Bin Li,

The Journal of Immunology

2004

77

C5a Receptor Deficiency Attenuates T Cell Function and Renal Disease in MRLlpr Mice

Scott E. Wenderfer, Baozhen Ke, Travis J. Hollmann,

Journal of the American Society of Nephrology

2005

73

Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer

Pei‐Chih Lee, Yueh‐Fu Fang, Hirohito Yamaguchi,

Cancer Cell

2018

71

C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse

Scott E. Wenderfer, Hongyu Wang, Baozhen Ke,

Molecular Immunology

2009

44

Epichaperome inhibition targets <i>TP53-</i>mutant AML and AML stem/progenitor cells

Bing Z. Carter, Po Yee Mak, Muharrem Müftüoğlu,

Blood

2023

24

Proteomic Profiling of Urinary Protein Excretion in the Factor H-Deficient Mouse

Michael Braun, Li Li, Baozhen Ke,

American Journal of Nephrology

2006

14

Selective Targeting of TP53-Y220C Mutant AML By PC14586 Results in TP53 Wild-Type Conformation and Synergistical Apoptosis Induction By Concomitant Inhibition of Xpo-1, MDM2, or Bcl-2

Bing Z. Carter, Po Yee Mak, Baozhen Ke,

Blood

2023

11

Page 1